ALC
Alcon Inc.
Price Chart
Latest Quote
$79.38
Current Price| Previous Close | $80.98 |
| Open | $79.65 |
| Day High | $80.15 |
| Day Low | $79.15 |
| Volume | 1,447,969 |
Stock Information
| Quarterly Dividend / Yield | $0.33 / 0.42% |
| Shares Outstanding | 491.20M |
| Total Debt | $5.24B |
| Cash Equivalents | $1.50B |
| Revenue | $10.18B |
| Net Income | $1.05B |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $39.14B |
| P/E Ratio | 37.80 |
| EPS (TTM) | $2.10 |
| Exchange | NYQ |
đ Custom Metrics & Score
Score: 18/42| Debt to Equity | 0.24 |
| Debt to Earnings | 0.93 |
| Current Ratio | 2.77 |
| Quick Ratio | 1.72 |
| Avg Revenue Growth | 4.88% |
| Profit Margin | 10.27% |
| Return on Equity | 4.72% |
| Avg FCF Growth | 188.18% |
| FCF Yield | 3.59% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $79.38 | 1,448,400 |
| 2026-01-30 | $80.98 | 1,224,500 |
| 2026-01-29 | $81.15 | 1,392,900 |
| 2026-01-28 | $80.42 | 1,077,400 |
| 2026-01-27 | $80.87 | 1,020,900 |
| 2026-01-26 | $80.79 | 637,400 |
| 2026-01-23 | $80.29 | 939,400 |
| 2026-01-22 | $81.02 | 1,015,000 |
| 2026-01-21 | $81.62 | 2,829,600 |
| 2026-01-20 | $79.06 | 1,872,300 |
| 2026-01-16 | $79.00 | 1,480,200 |
| 2026-01-15 | $79.67 | 1,125,600 |
| 2026-01-14 | $80.11 | 1,252,200 |
| 2026-01-13 | $78.99 | 1,941,200 |
| 2026-01-12 | $80.86 | 1,002,200 |
| 2026-01-09 | $80.13 | 1,400,000 |
| 2026-01-08 | $80.62 | 1,129,300 |
| 2026-01-07 | $81.02 | 1,292,100 |
| 2026-01-06 | $81.81 | 1,748,100 |
| 2026-01-05 | $80.65 | 1,534,700 |
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
đ° Latest News
Alcon Inc. (ALC): A Bull Case Theory
Insider Monkey âĸ 2026-02-03T01:57:06Z
Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-01-30T14:54:01Z
Is Alcon Inc.'s (VTX:ALC) Recent Stock Performance Influenced By Its Financials In Any Way?
Simply Wall St. âĸ 2026-01-26T05:17:23Z
Analysts Question STAAR Surgical Company (STAA)âs Post-Merger Standalone Valuation
Insider Monkey âĸ 2026-01-26T01:18:20Z
Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors
Barrons.com âĸ 2026-01-23T21:35:00Z
Why STAAR Surgical (STAA) Is Down 5.2% After Shareholders Reject Alcon Deal And Board Power Shifts
Simply Wall St. âĸ 2026-01-18T22:07:13Z
Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-01-16T14:32:25Z
STAAR CEO exits after company rejects Alcon buyout
MedTech Dive âĸ 2026-01-16T10:00:00Z
Why The Narrative Around Alcidion Group ASX ALC Is Shifting With New Fair Value Signals
Simply Wall St. âĸ 2026-01-11T09:12:33Z
Alcon Inc.'s (VTX:ALC) Intrinsic Value Is Potentially 56% Above Its Share Price
Simply Wall St. âĸ 2026-01-09T05:09:10Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $4,399,000,000 | $4,208,000,000 | $3,969,000,000 | $3,639,000,000 |
| Cost Of Revenue | $4,399,000,000 | $4,208,000,000 | $3,969,000,000 | $3,639,000,000 |
| Total Revenue | $9,911,000,000 | $9,455,000,000 | $8,717,000,000 | $8,291,000,000 |
| Operating Revenue | $9,836,000,000 | $9,370,000,000 | $8,654,000,000 | $8,222,000,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $192,000,000 | $189,000,000 | $134,000,000 | $120,000,000 |
| Total Expenses | $8,498,000,000 | $8,416,000,000 | $8,045,000,000 | $7,711,000,000 |
| Other Income Expense | $-37,000,000 | $-52,000,000 | $-79,000,000 | $-35,000,000 |
| Net Non Operating Interest Income Expense | $-120,000,000 | $-155,000,000 | $-130,000,000 | $-127,000,000 |
| Total Other Finance Cost | $12,000,000 | $11,000,000 | $12,000,000 | $10,000,000 |
| Interest Expense Non Operating | $192,000,000 | $189,000,000 | $134,000,000 | $120,000,000 |
| Operating Expense | $4,099,000,000 | $4,208,000,000 | $4,076,000,000 | $4,072,000,000 |
| Other Operating Expenses | $-27,000,000 | $171,000,000 | $306,000,000 | $154,000,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Net Interest Income | $-120,000,000 | $-155,000,000 | $-130,000,000 | $-127,000,000 |
| Interest Income | $84,000,000 | $45,000,000 | $16,000,000 | $3,000,000 |
| Normalized Income | $1,041,519,000 | $1,021,580,000 | $392,196,000 | $407,500,000 |
| Net Income From Continuing And Discontinued Operation | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Total Operating Income As Reported | $1,413,000,000 | $1,039,000,000 | $672,000,000 | $580,000,000 |
| Net Income Common Stockholders | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Net Income | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Net Income Including Noncontrolling Interests | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Net Income Continuous Operations | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Pretax Income | $1,256,000,000 | $832,000,000 | $463,000,000 | $418,000,000 |
| Special Income Charges | $1,000,000 | $-13,000,000 | $-21,000,000 | $-6,000,000 |
| Earnings From Equity Interest | $-8,000,000 | $0 | $0 | - |
| Interest Income Non Operating | $84,000,000 | $45,000,000 | $16,000,000 | $3,000,000 |
| Operating Income | $1,413,000,000 | $1,039,000,000 | $672,000,000 | $580,000,000 |
| Gross Profit | $5,512,000,000 | $5,247,000,000 | $4,748,000,000 | $4,652,000,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $2.05 | $1.96 | $0.68 | $0.76 |
| Basic EPS | $2.06 | $1.98 | $0.68 | $0.77 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-5,481,000 | $-4,420,000 | $-21,804,000 | $-3,500,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,705,000,000 | $2,294,000,000 | $1,799,000,000 | $1,792,000,000 |
| Total Unusual Items | $-29,000,000 | $-52,000,000 | $-79,000,000 | $-35,000,000 |
| Total Unusual Items Excluding Goodwill | $-29,000,000 | $-52,000,000 | $-79,000,000 | $-35,000,000 |
| Reconciled Depreciation | $1,228,000,000 | $1,221,000,000 | $1,123,000,000 | $1,219,000,000 |
| EBITDA (Bullshit earnings) | $2,676,000,000 | $2,242,000,000 | $1,720,000,000 | $1,757,000,000 |
| EBIT | $1,448,000,000 | $1,021,000,000 | $597,000,000 | $538,000,000 |
| Diluted Average Shares | $497,500,000 | $496,500,000 | $494,400,000 | $493,400,000 |
| Basic Average Shares | $494,400,000 | $493,000,000 | $491,400,000 | $490,000,000 |
| Diluted NI Availto Com Stockholders | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Tax Provision | $238,000,000 | $-142,000,000 | $128,000,000 | $42,000,000 |
| Other Special Charges | $-1,000,000 | $13,000,000 | $21,000,000 | $6,000,000 |
| Gain On Sale Of Security | $-30,000,000 | $-39,000,000 | $-58,000,000 | $-29,000,000 |
| Research And Development | $876,000,000 | $828,000,000 | $702,000,000 | $842,000,000 |
| Selling General And Administration | $3,250,000,000 | $3,209,000,000 | $3,068,000,000 | $3,076,000,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $4,020,000,000 | $2,638,000,000 | $1,062,000,000 | $1,586,000,000 |
| Total Assets | $30,347,000,000 | $29,614,000,000 | $29,165,000,000 | $27,999,000,000 |
| Total Non Current Assets | $24,038,000,000 | $23,967,000,000 | $23,972,000,000 | $22,613,000,000 |
| Other Non Current Assets | $115,000,000 | $119,000,000 | $96,000,000 | $54,000,000 |
| Non Current Prepaid Assets | $6,000,000 | $6,000,000 | $8,000,000 | $25,000,000 |
| Non Current Deferred Assets | $601,000,000 | $606,000,000 | $550,000,000 | $564,000,000 |
| Non Current Deferred Taxes Assets | $421,000,000 | $443,000,000 | $411,000,000 | $409,000,000 |
| Non Current Note Receivables | $45,000,000 | $44,000,000 | $22,000,000 | $20,000,000 |
| Non Current Accounts Receivable | $149,000,000 | $164,000,000 | $157,000,000 | $145,000,000 |
| Investmentin Financial Assets | $458,000,000 | $309,000,000 | $108,000,000 | $52,000,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $1,000,000 | $1,000,000 | $20,000,000 | $6,000,000 |
| Goodwill And Other Intangible Assets | $17,533,000,000 | $17,986,000,000 | $18,615,000,000 | $17,670,000,000 |
| Other Intangible Assets | $8,587,000,000 | $9,060,000,000 | $9,689,000,000 | $8,765,000,000 |
| Current Assets | $6,309,000,000 | $5,647,000,000 | $5,193,000,000 | $5,386,000,000 |
| Hedging Assets Current | $12,000,000 | $2,000,000 | $8,000,000 | $3,000,000 |
| Prepaid Assets | $117,000,000 | $112,000,000 | $107,000,000 | $92,000,000 |
| Inventory | $2,268,000,000 | $2,322,000,000 | $2,109,000,000 | $1,899,000,000 |
| Receivables | $2,082,000,000 | $2,110,000,000 | $1,989,000,000 | $1,814,000,000 |
| Other Receivables | $147,000,000 | $128,000,000 | $102,000,000 | $107,000,000 |
| Taxes Receivable | $82,000,000 | $96,000,000 | $112,000,000 | $114,000,000 |
| Accounts Receivable | $1,853,000,000 | $1,886,000,000 | $1,775,000,000 | $1,593,000,000 |
| Allowance For Doubtful Accounts Receivable | $-41,000,000 | $-44,000,000 | $-57,000,000 | $-55,000,000 |
| Gross Accounts Receivable | $1,894,000,000 | $1,930,000,000 | $1,832,000,000 | $1,648,000,000 |
| Cash Cash Equivalents And Short Term Investments | $1,830,000,000 | $1,101,000,000 | $980,000,000 | $1,578,000,000 |
| Cash And Cash Equivalents | $1,676,000,000 | $1,094,000,000 | $980,000,000 | $1,575,000,000 |
| Cash Equivalents | $1,298,000,000 | $824,000,000 | $699,000,000 | $1,329,000,000 |
| Cash Financial | $378,000,000 | $270,000,000 | $281,000,000 | $246,000,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $2,963,000,000 | $3,635,000,000 | $3,658,000,000 | $2,498,000,000 |
| Total Debt | $5,136,000,000 | $5,135,000,000 | $5,068,000,000 | $4,479,000,000 |
| Long Term Debt And Capital Lease Obligation | $4,967,000,000 | $5,011,000,000 | $4,900,000,000 | $4,305,000,000 |
| Long Term Debt | $4,538,000,000 | $4,676,000,000 | $4,541,000,000 | $3,966,000,000 |
| Current Debt And Capital Lease Obligation | $169,000,000 | $124,000,000 | $168,000,000 | $174,000,000 |
| Current Debt | $101,000,000 | $53,000,000 | $97,000,000 | $107,000,000 |
| Other Current Borrowings | $34,000,000 | $5,000,000 | $95,000,000 | $90,000,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $8,794,000,000 | $8,990,000,000 | $9,488,000,000 | $8,743,000,000 |
| Total Non Current Liabilities Net Minority Interest | $6,516,000,000 | $6,592,000,000 | $6,750,000,000 | $6,271,000,000 |
| Other Non Current Liabilities | $128,000,000 | $134,000,000 | $230,000,000 | $168,000,000 |
| Non Current Deferred Liabilities | $810,000,000 | $829,000,000 | $1,064,000,000 | $1,026,000,000 |
| Non Current Deferred Taxes Liabilities | $724,000,000 | $797,000,000 | $1,064,000,000 | $1,026,000,000 |
| Current Liabilities | $2,278,000,000 | $2,398,000,000 | $2,738,000,000 | $2,472,000,000 |
| Other Current Liabilities | $4,000,000 | $10,000,000 | $10,000,000 | $7,000,000 |
| Current Deferred Liabilities | $73,000,000 | $78,000,000 | $89,000,000 | $108,000,000 |
| Payables And Accrued Expenses | $1,497,000,000 | $1,601,000,000 | $1,736,000,000 | $1,624,000,000 |
| Interest Payable | $32,000,000 | $32,000,000 | $31,000,000 | $19,000,000 |
| Payables | $982,000,000 | $1,065,000,000 | $1,200,000,000 | $1,241,000,000 |
| Other Payable | $46,000,000 | $69,000,000 | $66,000,000 | $58,000,000 |
| Total Tax Payable | $163,000,000 | $185,000,000 | $273,000,000 | $280,000,000 |
| Income Tax Payable | $104,000,000 | $114,000,000 | $175,000,000 | $187,000,000 |
| Accounts Payable | $773,000,000 | $811,000,000 | $861,000,000 | $903,000,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $21,553,000,000 | $20,624,000,000 | $19,677,000,000 | $19,256,000,000 |
| Total Equity Gross Minority Interest | $21,553,000,000 | $20,624,000,000 | $19,677,000,000 | $19,256,000,000 |
| Stockholders Equity | $21,553,000,000 | $20,624,000,000 | $19,677,000,000 | $19,256,000,000 |
| Gains Losses Not Affecting Retained Earnings | $21,533,000,000 | $20,604,000,000 | $19,657,000,000 | $19,236,000,000 |
| Long Term Equity Investment | $293,000,000 | $10,000,000 | $0 | - |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $5,083,676 | $6,400,000 | $7,900,000 | $9,600,000 |
| Ordinary Shares Number | $494,616,324 | $493,244,479 | $490,086,981 | $490,086,981 |
| Share Issued | $499,700,000 | $499,644,479 | $497,986,981 | $499,686,981 |
| Tangible Book Value | $4,020,000,000 | $2,638,000,000 | $1,062,000,000 | $1,586,000,000 |
| Invested Capital | $26,192,000,000 | $25,353,000,000 | $24,315,000,000 | $23,329,000,000 |
| Working Capital | $4,031,000,000 | $3,249,000,000 | $2,455,000,000 | $2,914,000,000 |
| Capital Lease Obligations | $497,000,000 | $406,000,000 | $430,000,000 | $406,000,000 |
| Total Capitalization | $26,091,000,000 | $25,300,000,000 | $24,218,000,000 | $23,222,000,000 |
| Capital Stock | $20,000,000 | $20,000,000 | $20,000,000 | $20,000,000 |
| Common Stock | $20,000,000 | $20,000,000 | $20,000,000 | $20,000,000 |
| Employee Benefits | $611,000,000 | $618,000,000 | $556,000,000 | $772,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $406,000,000 | $434,000,000 | $396,000,000 | $595,000,000 |
| Non Current Deferred Revenue | $86,000,000 | $32,000,000 | - | - |
| Long Term Capital Lease Obligation | $429,000,000 | $335,000,000 | $359,000,000 | $339,000,000 |
| Current Deferred Revenue | $73,000,000 | $78,000,000 | $89,000,000 | $108,000,000 |
| Current Capital Lease Obligation | $68,000,000 | $71,000,000 | $71,000,000 | $67,000,000 |
| Line Of Credit | $67,000,000 | $48,000,000 | $2,000,000 | $17,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $531,000,000 | $550,000,000 | $465,000,000 | $489,000,000 |
| Current Provisions | $4,000,000 | $35,000,000 | $270,000,000 | $70,000,000 |
| Current Accrued Expenses | $515,000,000 | $536,000,000 | $536,000,000 | $383,000,000 |
| Investments And Advances | $751,000,000 | $319,000,000 | $108,000,000 | $52,000,000 |
| Available For Sale Securities | $457,000,000 | $308,000,000 | $88,000,000 | $46,000,000 |
| Investmentsin Associatesat Cost | $293,000,000 | $10,000,000 | $0 | - |
| Goodwill | $8,946,000,000 | $8,926,000,000 | $8,926,000,000 | $8,905,000,000 |
| Net PPE | $4,838,000,000 | $4,723,000,000 | $4,416,000,000 | $4,083,000,000 |
| Accumulated Depreciation | $-3,199,000,000 | $-2,975,000,000 | $-2,750,000,000 | $-2,649,000,000 |
| Gross PPE | $8,037,000,000 | $7,698,000,000 | $7,166,000,000 | $6,732,000,000 |
| Construction In Progress | $940,000,000 | $1,023,000,000 | $955,000,000 | $790,000,000 |
| Other Properties | $36,000,000 | $31,000,000 | $29,000,000 | $29,000,000 |
| Machinery Furniture Equipment | $4,270,000,000 | $3,989,000,000 | $3,694,000,000 | $3,547,000,000 |
| Buildings And Improvements | $2,731,000,000 | $2,603,000,000 | $2,438,000,000 | $2,313,000,000 |
| Land And Improvements | $60,000,000 | $52,000,000 | $50,000,000 | $53,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,631,000,000 | $1,691,000,000 | $1,475,000,000 | $1,394,000,000 |
| Work In Process | $199,000,000 | $197,000,000 | $201,000,000 | $169,000,000 |
| Raw Materials | $438,000,000 | $434,000,000 | $433,000,000 | $336,000,000 |
| Other Short Term Investments | $154,000,000 | $7,000,000 | $0 | $3,000,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $1,407,000,000 | $537,000,000 | $472,000,000 | $165,000,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $2,077,000,000 | $1,388,000,000 | $1,217,000,000 | $1,345,000,000 |
| Cash Flow From Continuing Operating Activities | $2,077,000,000 | $1,388,000,000 | $1,217,000,000 | $1,345,000,000 |
| Operating Gains Losses | $-33,000,000 | $27,000,000 | $10,000,000 | $13,000,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-670,000,000 | $-851,000,000 | $-745,000,000 | $-1,180,000,000 |
| Investing Cash Flow | $-1,167,000,000 | $-1,094,000,000 | $-1,865,000,000 | $-1,198,000,000 |
| Cash Flow From Continuing Investing Activities | $-1,167,000,000 | $-1,094,000,000 | $-1,865,000,000 | $-1,198,000,000 |
| Net Other Investing Changes | $-8,000,000 | $-2,000,000 | $-485,000,000 | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $-322,000,000 | $-211,000,000 | $-8,000,000 | $-123,000,000 |
| Cash Flow From Continuing Financing Activities | $-322,000,000 | $-211,000,000 | $-8,000,000 | $-123,000,000 |
| Net Other Financing Charges | $-55,000,000 | $-88,000,000 | $-116,000,000 | $-6,000,000 |
| Cash Dividends Paid | $-130,000,000 | $-116,000,000 | $-100,000,000 | $-54,000,000 |
| Common Stock Dividend Paid | $-130,000,000 | $-116,000,000 | $-100,000,000 | - |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-196,000,000 | $-113,000,000 | $-2,378,000,000 | $-115,000,000 |
| Issuance Of Debt | $59,000,000 | $106,000,000 | $2,586,000,000 | $52,000,000 |
| End Cash Position | $1,676,000,000 | $1,094,000,000 | $980,000,000 | $1,575,000,000 |
| Beginning Cash Position | $1,094,000,000 | $980,000,000 | $1,575,000,000 | $1,557,000,000 |
| Effect Of Exchange Rate Changes | $-6,000,000 | $31,000,000 | $61,000,000 | $-6,000,000 |
| Changes In Cash | $588,000,000 | $83,000,000 | $-656,000,000 | $24,000,000 |
| Net Issuance Payments Of Debt | $-137,000,000 | $-7,000,000 | $208,000,000 | $-63,000,000 |
| Net Long Term Debt Issuance | $-137,000,000 | $-7,000,000 | $208,000,000 | $-20,000,000 |
| Long Term Debt Payments | $-196,000,000 | $-113,000,000 | $-2,378,000,000 | $-72,000,000 |
| Long Term Debt Issuance | $59,000,000 | $106,000,000 | $2,586,000,000 | $52,000,000 |
| Net Investment Purchase And Sale | $-269,000,000 | $-231,000,000 | $31,000,000 | $-18,000,000 |
| Sale Of Investment | $9,000,000 | $2,000,000 | $81,000,000 | $1,000,000 |
| Purchase Of Investment | $-278,000,000 | $-233,000,000 | $-50,000,000 | $-19,000,000 |
| Net Business Purchase And Sale | $-220,000,000 | $-10,000,000 | $-666,000,000 | $0 |
| Purchase Of Business | $-220,000,000 | $-10,000,000 | $-666,000,000 | $0 |
| Net Intangibles Purchase And Sale | $-197,000,000 | $-193,000,000 | $-109,000,000 | $-480,000,000 |
| Purchase Of Intangibles | $-197,000,000 | $-193,000,000 | $-109,000,000 | $-480,000,000 |
| Net PPE Purchase And Sale | $-473,000,000 | $-658,000,000 | $-636,000,000 | $-700,000,000 |
| Purchase Of PPE | $-473,000,000 | $-658,000,000 | $-636,000,000 | $-700,000,000 |
| Taxes Refund Paid | $-326,000,000 | $-255,000,000 | $-178,000,000 | $-175,000,000 |
| Interest Received Cfo | $69,000,000 | $33,000,000 | $14,000,000 | $3,000,000 |
| Interest Paid Cfo | $-182,000,000 | $-176,000,000 | $-111,000,000 | $-108,000,000 |
| Change In Working Capital | $-189,000,000 | $-404,000,000 | $-522,000,000 | $-314,000,000 |
| Change In Other Current Liabilities | $-44,000,000 | $51,000,000 | $-30,000,000 | $174,000,000 |
| Change In Other Current Assets | $-28,000,000 | $-23,000,000 | $-63,000,000 | $-24,000,000 |
| Change In Payables And Accrued Expense | $-15,000,000 | $-51,000,000 | $-48,000,000 | $60,000,000 |
| Change In Payable | $-15,000,000 | $-51,000,000 | $-48,000,000 | $60,000,000 |
| Change In Account Payable | $-15,000,000 | $-51,000,000 | $-48,000,000 | $60,000,000 |
| Change In Inventory | $-47,000,000 | $-271,000,000 | $-217,000,000 | $-326,000,000 |
| Change In Receivables | $-55,000,000 | $-110,000,000 | $-164,000,000 | $-198,000,000 |
| Changes In Account Receivables | $-55,000,000 | $-110,000,000 | $-164,000,000 | $-198,000,000 |
| Other Non Cash Items | $52,000,000 | $-62,000,000 | $105,000,000 | $91,000,000 |
| Stock Based Compensation | $150,000,000 | $144,000,000 | $140,000,000 | $138,000,000 |
| Provisionand Write Offof Assets | $52,000,000 | $21,000,000 | $187,000,000 | $57,000,000 |
| Amortization Of Securities | $0 | $7,000,000 | $-14,000,000 | $3,000,000 |
| Deferred Tax | $238,000,000 | $-142,000,000 | $128,000,000 | $42,000,000 |
| Deferred Income Tax | $238,000,000 | $-142,000,000 | $128,000,000 | $42,000,000 |
| Depreciation Amortization Depletion | $1,228,000,000 | $1,221,000,000 | $1,123,000,000 | $1,219,000,000 |
| Depreciation And Amortization | $1,228,000,000 | $1,221,000,000 | $1,123,000,000 | $1,219,000,000 |
| Amortization Cash Flow | $752,000,000 | $745,000,000 | $715,000,000 | $815,000,000 |
| Amortization Of Intangibles | $752,000,000 | $745,000,000 | $715,000,000 | $815,000,000 |
| Depreciation | $476,000,000 | $476,000,000 | $408,000,000 | $404,000,000 |
| Earnings Losses From Equity Investments | $8,000,000 | $0 | $0 | - |
| Gain Loss On Sale Of PPE | $-41,000,000 | $27,000,000 | $10,000,000 | $13,000,000 |
| Net Income From Continuing Operations | $1,018,000,000 | $974,000,000 | $335,000,000 | $376,000,000 |
| Net Short Term Debt Issuance | - | $43,000,000 | $-42,000,000 | $-43,000,000 |
| Short Term Debt Payments | - | $-34,000,000 | $-42,000,000 | $-43,000,000 |
| Short Term Debt Issuance | - | $77,000,000 | $0 | $0 |
| Sale Of PPE | - | - | $0 | $0 |